Anúncio
Anúncio

LIXT

LIXT logo

Lixte Biotechnology Holdings, Inc. Common Stock

3.63
USD
Patrocinado
-0.12
-3.17%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

3.68

+0.05
+1.35%

Relatórios de Lucros LIXT

Rácio de surpresa positiva

Nenhum Dado Disponível para LIXT

%

Próximo Relatório

Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
--

Lixte Biotechnology Holdings, Inc. Common Stock earnings per share and revenue

On 12 de nov. de 2025, LIXT reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Lixte Biotechnology Holdings, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 23 de mar. de 2026.
Based on -- analistas, Lixte Biotechnology Holdings, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio